Inibidor de Janus Kinase - Tofacitinibe Associado ao Pênfigo: Uma análise dos dados do Sistema de Notificação de Eventos Adversos do FDA
ExpExpert Opin Drug Saf. 2023;22(12):1317–1320 doi: 10.1080/14740338.2023.2248872
This study presents initial data suggesting an association between the use of JAK inhibitors and pemphigus. This research used the FAERS database to investigate connections between JAK inhibitor usage and the occurrence of pemphigus as an adverse event.